Dyskeratosis Congenita X Linked C1148551
An X-linked disorder causing abnormal skin pigmentation, nail changes, and oral leukoplakia. Primarily affects males. Severe complications include bone marrow failure, treated with transplants and supportive measures.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Allogeneic hematopoietic stem cell transplantation
Bone marrow transplant to replace defective stem cells and restore healthy blood cell production. This is the only curative option for bone marrow failure in dyskeratosis congenita.
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Comprehensive cancer surveillance program
Regular screening including annual skin examinations, ENT evaluations, and imaging for early detection of malignancies. Patients have significantly elevated cancer risk.
Additional treatment options
Growth factors and supportive hematologic care
Use of erythropoietin-stimulating agents and granulocyte colony-stimulating factor to support blood cell production. Addresses cytopenias while awaiting definitive transplant.
medicationSun protection and dermatologic care
Strict sun avoidance with broad-spectrum sunscreen, protective clothing, and regular dermatology consultations. Addresses the characteristic skin pigmentation and photosensitivity.
lifestyleAndrogen therapy for bone marrow failure
Oxymetholone or similar anabolic steroids may improve blood counts in some patients with bone marrow failure, particularly when transplant is not immediately available.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Dyskeratosis Congenita X Linked C1148551?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Dyskeratosis Congenita X Linked C1148551. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy